Research output per year
Research output per year
Personal profile
Expertises
None
Main research areas
None
Current research
None
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Jon Alexander Lykkegaard Andersen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 11 Journal article
-
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis
Andersen, J. L., Johansen, J. S., Urbanska, E. M., Meldgaard, P., Hjorth-Hansen, P., Kristiansen, C., Stelmach, M., Santoni-Rugiu, E., Ulhøi, M. P., Højgaard, B., Jensen, M. S., Dydensborg, A. B., Dünweber, C. & Hansen, K. H., 2024, In: Lung Cancer Management. 13, 1, p. LMT68 LMT68.Research output: Contribution to journal › Journal article › Research › peer-review
-
Clinical outcomes of ALK+ non-small cell lung cancer in Denmark
Hansen, K. H., Johansen, J. S., Urbanska, E. M., Meldgaard, P., Hjorth-Hansen, P., Kristiansen, C., Stelmach, M., Santoni-Rugiu, E., Ulhøi, M. P., Dydensborg, A. B., Dünweber, C. & Andersen, J. L., Dec 2023, In: Acta Oncologica. 62, 12, p. 1775-1783 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus) -
KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study
Frost, M. G., Jensen, K. J., Gotfredsen, D. R., Sørensen, A. M. S., Ankarfeldt, M. Z., Louie, K. S., Sroczynski, N., Jakobsen, E., Andersen, J. L., Jimenez-Solem, E. & Petersen, T. S., Apr 2023, In: Lung cancer. 178, p. 172-182 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus) -
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
Mouritzen, M. T., Junker, K. F., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A.-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F. & Andersen, J. L. & 7 others, , Apr 2022, In: Acta Oncologica. 61, 4, p. 409-416 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
13 Citations (Scopus) -
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy
Mouritzen, M. T., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A.-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L. & Frary, J. M. C. & 5 others, , 28 Sept 2021, In: Cancers. 13, 19, 4846.Research output: Contribution to journal › Journal article › Research › peer-review